Sanyo Chemical Industries Ltd
TSE:4471
Sanyo Chemical Industries Ltd
TSE:4471
Price:
3 975
JPY
-0.25%
Market Closed
Market Cap:
87.9B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Sanyo Chemical Industries Ltd
3975
-10 (-0.25%)
| 52 Week Range |
3 510
4 470
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Sanyo Chemical Industries Ltd
Balance Sheet
Balance Sheet Decomposition
Sanyo Chemical Industries Ltd
Sanyo Chemical Industries Ltd
| Current Assets | 92.6B |
| Cash & Short-Term Investments | 21.8B |
| Receivables | 38.5B |
| Other Current Assets | 32.3B |
| Non-Current Assets | 94.5B |
| Long-Term Investments | 30.6B |
| PP&E | 48B |
| Intangibles | 6.7B |
| Other Non-Current Assets | 9.2B |
| Current Liabilities | 38.3B |
| Accounts Payable | 24.4B |
| Accrued Liabilities | 2B |
| Short-Term Debt | 4.4B |
| Other Current Liabilities | 7.5B |
| Non-Current Liabilities | 12.4B |
| Long-Term Debt | 1.4B |
| Other Non-Current Liabilities | 10.9B |
Balance Sheet
Sanyo Chemical Industries Ltd
Sanyo Chemical Industries Ltd
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
16 016
|
19 323
|
23 138
|
17 377
|
19 151
|
18 009
|
23 647
|
18 171
|
17 114
|
27 240
|
|
| Cash Equivalents |
16 016
|
19 323
|
23 138
|
17 377
|
19 151
|
18 009
|
23 647
|
18 171
|
17 114
|
27 240
|
|
| Total Receivables |
45 694
|
41 647
|
41 061
|
48 638
|
49 222
|
42 543
|
41 481
|
46 323
|
45 779
|
44 975
|
|
| Accounts Receivables |
45 694
|
41 647
|
41 061
|
48 638
|
49 222
|
42 543
|
41 481
|
46 323
|
45 779
|
44 975
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
20 462
|
17 966
|
18 415
|
20 746
|
25 016
|
23 963
|
22 633
|
27 586
|
32 347
|
31 133
|
|
| Other Current Assets |
2 338
|
2 061
|
2 720
|
2 181
|
1 664
|
1 320
|
1 579
|
1 684
|
2 084
|
2 581
|
|
| Total Current Assets |
84 510
|
80 997
|
85 334
|
88 942
|
95 053
|
85 835
|
89 340
|
93 764
|
97 324
|
105 929
|
|
| PP&E Net |
58 766
|
60 870
|
63 530
|
69 883
|
62 324
|
60 716
|
61 255
|
61 389
|
59 791
|
51 477
|
|
| PP&E Gross |
58 766
|
60 870
|
63 530
|
69 883
|
62 324
|
60 716
|
61 255
|
61 389
|
59 791
|
51 477
|
|
| Accumulated Depreciation |
137 113
|
151 033
|
153 752
|
157 572
|
160 666
|
164 754
|
170 926
|
176 711
|
180 402
|
185 122
|
|
| Intangible Assets |
1 332
|
2 163
|
1 987
|
2 115
|
2 416
|
2 497
|
3 585
|
5 248
|
7 877
|
7 563
|
|
| Goodwill |
1 201
|
934
|
801
|
667
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
2
|
0
|
3
|
7
|
984
|
2 232
|
2 937
|
4 012
|
4 145
|
3 545
|
|
| Long-Term Investments |
33 547
|
27 484
|
32 602
|
33 876
|
29 145
|
22 982
|
32 079
|
29 274
|
27 575
|
30 701
|
|
| Other Long-Term Assets |
1 804
|
2 870
|
2 606
|
3 689
|
3 708
|
4 611
|
6 527
|
6 507
|
5 470
|
6 603
|
|
| Other Assets |
1 201
|
934
|
801
|
667
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
181 029
N/A
|
175 321
-3%
|
186 863
+7%
|
199 179
+7%
|
193 630
-3%
|
178 873
-8%
|
195 723
+9%
|
200 194
+2%
|
202 182
+1%
|
205 818
+2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
26 153
|
23 298
|
25 445
|
33 454
|
30 595
|
23 115
|
23 303
|
26 059
|
25 574
|
29 317
|
|
| Accrued Liabilities |
4 989
|
4 988
|
5 186
|
5 346
|
5 769
|
5 169
|
6 654
|
6 485
|
6 150
|
2 100
|
|
| Short-Term Debt |
13 829
|
5 371
|
5 708
|
2 625
|
6 221
|
5 867
|
6 874
|
6 887
|
7 847
|
8 682
|
|
| Current Portion of Long-Term Debt |
879
|
1 171
|
1 515
|
2 212
|
1 964
|
1 400
|
1 400
|
850
|
474
|
505
|
|
| Other Current Liabilities |
6 416
|
7 949
|
6 610
|
6 560
|
7 975
|
7 215
|
7 991
|
7 623
|
6 893
|
12 915
|
|
| Total Current Liabilities |
52 266
|
42 777
|
44 464
|
50 197
|
52 524
|
42 766
|
46 222
|
47 904
|
46 938
|
53 519
|
|
| Long-Term Debt |
3 784
|
8 320
|
7 981
|
5 762
|
3 800
|
2 400
|
1 000
|
150
|
1 909
|
1 516
|
|
| Deferred Income Tax |
5 342
|
4 214
|
5 170
|
4 568
|
3 044
|
1 758
|
3 682
|
3 350
|
2 772
|
2 938
|
|
| Minority Interest |
5 860
|
6 265
|
6 047
|
6 170
|
3 251
|
2 462
|
2 477
|
2 552
|
2 927
|
2 540
|
|
| Other Liabilities |
1 949
|
1 726
|
1 597
|
2 382
|
1 639
|
1 852
|
1 868
|
1 758
|
1 569
|
6 268
|
|
| Total Liabilities |
69 201
N/A
|
63 302
-9%
|
65 259
+3%
|
69 079
+6%
|
64 258
-7%
|
51 238
-20%
|
55 249
+8%
|
55 714
+1%
|
56 115
+1%
|
66 781
+19%
|
|
| Equity | |||||||||||
| Common Stock |
13 051
|
13 051
|
13 051
|
13 051
|
13 051
|
13 051
|
13 051
|
13 051
|
13 051
|
13 051
|
|
| Retained Earnings |
75 000
|
80 163
|
88 697
|
95 544
|
98 350
|
103 033
|
106 662
|
109 713
|
111 762
|
99 488
|
|
| Additional Paid In Capital |
12 194
|
12 194
|
12 194
|
12 194
|
12 290
|
11 246
|
13 243
|
13 243
|
13 270
|
13 270
|
|
| Unrealized Security Profit/Loss |
13 601
|
0
|
12 790
|
13 656
|
10 263
|
6 122
|
11 069
|
9 623
|
8 816
|
11 584
|
|
| Treasury Stock |
5 722
|
0
|
5 745
|
5 752
|
5 856
|
5 858
|
5 848
|
5 781
|
5 730
|
5 675
|
|
| Other Equity |
3 704
|
2 669
|
617
|
1 407
|
1 274
|
41
|
2 297
|
4 631
|
4 898
|
7 319
|
|
| Total Equity |
111 828
N/A
|
112 019
+0%
|
121 604
+9%
|
130 100
+7%
|
129 372
-1%
|
127 635
-1%
|
140 474
+10%
|
144 480
+3%
|
146 067
+1%
|
139 037
-5%
|
|
| Total Liabilities & Equity |
181 029
N/A
|
175 321
-3%
|
186 863
+7%
|
199 179
+7%
|
193 630
-3%
|
178 873
-8%
|
195 723
+9%
|
200 194
+2%
|
202 182
+1%
|
205 818
+2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
22
|
22
|
22
|
22
|
22
|
22
|
22
|
22
|
22
|
22
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
